Bruker Corporation— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$6.24B
↑+7.5% +$435Mvs FY2024
Total Liabilities
$3.73B
↓-6.5% -$260Mvs FY2024
Equity
$2.46B
↑+37.9% +$675Mvs FY2024
Cash
$299M
↑+62.9% +$115Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $6.24B | $5.81B |
| Current Assets | $2.21B | $2.05B |
| Cash | $299M | $183M |
| ST Investments | $0 | $0 |
| Receivables | $545M | $566M |
| Inventory | $1.09B | $1.07B |
| Other Current | $274M | $237M |
| Non-Current Assets | $4.03B | $3.75B |
| PPE | $745M | $669M |
| Goodwill | $1.55B | $1.51B |
| Intangibles | $900M | $913M |
| Investments | $0 | $0 |
| Other Non-Current | $837M | $664M |
| Total Liab+Eq | $6.19B | $5.77B |
| Current Liab. | $1.28B | $1.28B |
| Accounts Payable | $216M | $234M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $441M | $438M |
| Other CL | $622M | $609M |
| Non-Current Liab. | $2.45B | $2.71B |
| Long-Term Debt | $1.87B | $2.09B |
| Other LT Liab. | $583M | $616M |
| Equity | $2.46B | $1.78B |
| Retained Earnings | $2.36B | $2.41B |
| Other Equity | $95M | $0 |
QuarterCharts · SEC EDGAR data · BRKR · Comparing FY2025 vs FY2024